Preparation and characterization of polyclonal antibodies against ARL-1 protein

World Journal of Gastroenterology

Volumn 9, Issue 7, 2003, Pages 1455-1459

  Jin, Jun Fei ^a   Yuan, Liu Di ^a   Liu, Li ^a   Zhao, Zhu Jiang ^a   Xie, Wei ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDEHYDE REDUCTASE LIKE 1 PROTEIN; BACTERIAL PROTEIN; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; POLYCLONAL ANTIBODY; SEPHAROSE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL TISSUE; ARTICLE; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION; IMMUNIZATION; LIVER CANCER; LIVER CELL CARCINOMA; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RABBIT; SERUM; WESTERN BLOTTING;

EID: 0041966017     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i7.1455     Document Type: Article

References (58)

1. Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M. Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes. Arch Mal Coeur Vaiss 2002; 95: 701-708
2. Cisarik-Fredenburg P. Discoveries in research on diabetic keratopathy. Optometry 2001; 72: 691-704
3. Chandra D, Jackson EB, Ramana KV, Kelley R, Srivastava SK, Bhatnagar A. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes 2002; 51: 3095-3101
4. Naya Y, Soh J, Ochiai A, Mizutani Y, Kawauchi A, Fujito A, Ushijima S, Ono T, Iwamoto N, Aoki T, Imada N, Nakamura N, Yabe-Nishimura C, Miki T. Erythrocyte aldose reductase correlates with erectile dysfunction in diabetic patients. Int J Impot Res 2002; 14: 213-216
5. Jung SH, Lee YS, Lee S, Lim SS, Kim YS, Shin KH. Isoflavonoids from the rhizomes of Belamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues. Arch Pharm Res 2002; 25: 306-312
6. Kryvko IuIa, Kozyts'kyi ZIa, Serhiienko OO, Kuchmerovs'ka TM, Velykyi MM. Diabetic neuropathies. Metabolism of sorbitol in sciatic nerve tissue in streptozotocin diabetes. Ukr Biokhim Zh 2001; 73: 69-74
7. Chang KC, Paek KS, Kim HJ, Lee YS, Yabe-Nishimura C, Seo HG. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 2002; 61: 1184-1191
8. Aukunuru JV, Sunkara G, Ayalasomayajula SP, DeRuiter J, Clark RC, Kompella UB. A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications. Pharm Res 2002; 19: 278-285
9. Park HK, Ahn CW, Lee GT, Kim SJ, Song YD, Lim SK, Kim KR, Huh KB, Lee HC. (AC) (n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract 2002; 55: 151-157
10. Kaul CL, Ramarao P. The role of aldose reductase inhibitors in diabetic complications: Recent trends. Methods Find Exp Clin Pharmacol 2001; 23: 465-475
11. Colciago A, Negri-Cesi P, Celotti F. Pathogenesis of diabetic neuropathy-do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves? Exp Clin Endocrinol Diabetes 2002; 110: 22-26
12. Hansen SH. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 2001; 17: 330-346
13. Raptis AE, Viberti G. Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2001; 109(Suppl): 424-437
14. Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J, Sakamoto N. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 2001; 24: 1776-1782
15. Rippin JD, Patel A, Bain SC. Genetics of diabetic nephropathy. Best Pract Res Clin Endocrinol Metab 2001; 15: 345-358
16. Kubo E, Maekawa K, Tanimoto T, Fujisawa S, Akagi Y. Biochemical and morphological changes during development of sugar cataract in otsuka long-evans tokushima fatty (OLETF) rat. Exp Eye Res 2001; 73: 375-381
17. Wallner EI, Wada J, Tramonti G, Lin S, Srivastava SK, Kanwar YS. Relevance of aldo-keto reductase family members to the pathobiology of diabetic nephropathy and renal development. Ren Fail 2001; 23: 311-320
18. Zeindl-Eberhart E, Klugbauer S, Dimitrijevic N, Jungblut PR, Lamer S, Rabes HM. Proteome analysis of rate hepatomas: Carcinogen-dependent tumor-associated protein variants. Electrophoresis 2001; 22: 3009-3018
19. Lee KW, Ko BC, Jiang Z, Cao D, Chung SS. Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs 2001; 12: 129-132
20. Kelly VP, Ireland LS, Ellis EM, Hayes JD. Purification from rat liver of a novel constitutively expressed member of the aldo-keto reductase 7 family that is widely distributed in extrahepatic tissues. Biochem J 2000; 348: 389-400
21. Muzio G, Salvo RA, Taniguchi N, Maggiora M, Canuto RA. 4-Hydroxynonenal metabolism by aldo/keto reductase in hepatoma cells. Adv Exp Med Biol 1999; 463: 445-452
22. Cao D, Fan ST, Chung SS. Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem 1998; 273: 11429-11435
23. Scuric Z, Stain SC, Anderson WF, Hwang JJ. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology 1998; 27: 943-950
24. Zeindl-Eberhart E, Jungblut PR, Otto A, Kerler R, Rabes HM. Further characterization of a rat hepatoma-derived aldose-reductase-like protein-organ distribution and modulation in vitro. Eur J Biochem 1997; 247: 792-800
25. Takahashi M, Hoshi A, Fujii J, Miyoshi E, Kasahara T, Suzuki K, Aozasa K, Taniguchi N. Induction of aldose reductase gene expression in LEC rats during the development of the hereditary hepatitis and hepatoma. Jpn J Cancer Res 1996; 87: 337-341
26. Takahashi M, Fujii J, Miyoshi E, Hoshi A, Taniguchi N. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: Implication in detoxification of cytotoxic aldehydes. Int J Cancer 1995; 62: 749-754
27. Canuto RA, Ferro M, Muzio G, Bassi AM, Leonarduzzi G, Maggiora M, Adamo D, Poli G, Lindahl R. Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis 1994; 15: 1359-1364
28. Zeindl-Eberhart E, Jungblut PR, Otto A, Rabes HM. Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. J Biol Chem 1994; 269: 14589-14594
29. Zeindl-Eberhart E, Jungblut P, Rabes HM. Expression of tumor-associated protein variants in chemically induced rat hepatomas and transformed rat liver cell lines determined by two-dimensional electrophoresis. Electrophoresis 1994; 15: 372-381
30. Martinez A, Aigueperse C, Val P, Dussault M, Tournaire C, Berger M, Veyssiere G, Jean C, Lefrancois Martinez A. Physiological functions and hormonal regulation of mouse vas deferens protein (AKR1B7) in steroidogenic tissues. Chem Biol Interact 2001; 130-132: 903-917
31. Ho HT, Jenkins NA, Copeland NG, Gilbert DJ, Winkles JA, Louie HW, Lee FK, Chung SS, Chung SK. Comparisons of genomic structures and chromosomal locations of the mouse aldose reductase and aldose reductase-like genes. Eur J Biochem 1999; 259: 726-730
32. Fabre S, Darne C, Veyssiere G, Jean C. Protein kinase C pathway potentiates androgen-mediated gene expression of the mouse vas deferens specific aldose reductase-like protein (MVDP). Mol Cell Endocrinol 1996; 124: 79-86
33. Lau ET, Cao D, Lin C, Chung SK, Chung SS. Tissue-specific expression of two aldose reductase-like genes in mice: Abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. Biochem J 1995; 312: 609-615
34. Gui T, Tanimoto T, Kokai Y, Nishimura C. Presence of a closely related subgroup in the aldo-ketoreductase family of the mouse. Eur J Biochem 1995; 227: 448-453
35. Fabre S, Manin M, Pailhoux E, Veyssiere G, Jean C. Identification of a functional androgen response element in the promoter of the gene for the androgen-regulated aldose reductase-like protein specific to the mouse vas deferens. J Biol Chem 1994; 269: 5857-5864
36. Pailhoux E, Martinez A, Veyssiere G, Tournaire C, Berger M, Jean C. Characterization of cDNA and of the gene corresponding to androgen-dependent protein of the vas deferens in mice. Ann Endocrinol (Paris) 1991; 52: 437-440
37. Pailhoux EA, Martinez A, Veyssiere GM, Jean CG. Androgen-dependent protein from mouse vas deferens. cDNA cloning and protein homology with the aldo-keto reductase superfamily. J Biol Chem 1990; 265: 19932-19936
38. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus. Diabet Med 2000; 17: 111-118
39. Bain SC, Chowdhury TA. Genetics of diabetic nephropathy and microalbuminuria. J R Soc Med 2000; 93: 62-66
40. Glickman M, Malek RL, Kwitek-Black AE, Jacob HJ, Lee NH. Molecular cloning, tissue-specific expression, and chromosomal localization of a novel nerve growth factor-regulated G-protein-coupled receptor, nrg-1. Mol Cell Neurosci 1999; 14: 141-152
41. Winkles JA. Serum- and polypeptide growth factor-inducible gene expression in mouse fibroblasts. Prog Nucleic Acid Res Mol Biol 1998; 58: 41-78
42. Frank S, Werner S. The human homologue of the yeast CHL1 gene is a novel keratinocyte growth factor-regulated gene. J Biol Chem 1996; 271: 24337-24340
43. De Boer WI, Schuller AG, Vermey M, Van Der Kwast TH. Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol 1994; 145: 1199-1207
44. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 1559-1571
45. Kaneko M, Carper D, Nishimura C, Millen J, Bock M, Hohman TC. Induction of aldose reductase expression in rat kidney mesangial cells and Chinese hamster ovary cells under hypertonic conditions. Exp Cell Res 1990; 188: 135-140
46. Li H, Nobukuni Y, Gui T, Yabe-Nishimura C. Characterization of genomic regions directing the cell-specific expression of the mouse aldose reductase gene. Biochem Biophys Res Commun 1999; 255: 759-764
47. Ye Q, Hyndman D, Li X, Flynn TG, Jia Z. Crystal structure of CHO reductase, a member of the aldo-keto reductase superfamily. Proteins 2000; 38: 41-48
48. Qin LX, Tang ZY. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 193-199
49. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
50. Wu MC, Shen F. Progress in research of liver surgery in China. World J Gastroenterol 2000; 6: 773-776
51. Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7: 208-215
52. Yip D, Findlay M, Boyer M, Tattersall MH. Hepatocellular carcinoma in central Sydney: A 10 year review of patients seen in a medical oncology department. World J Gastroenterol 1999; 5: 483-487
53. Sithinamsuwan P, Piratvisuth T, Tanomkiat W, Apakupakul N, Tongyoo S. Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital. World J Gastroenterol 2000; 6: 339-343
54. Niu Q, Tang ZY, Ma ZC, Qin LX, Zhang LH. Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 2000; 6: 565-568
55. Jiang YF, Yang ZH, Hu JQ. Recurrence or metastasis of HCC: Predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 2000; 6: 61-65
56. He P, Tang ZY, Ye SL, Liu BB. Relationship between expression of α-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma. World J Gastroenterol 1999; 5: 111-115
57. Parks RW, Garden OJ. Liver resection for cancer. World J Gastroenterol 2001; 7: 766-771
58. Wu ZQ, Fan J, Qiu SJ, Zhou J, Tang ZY. The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer. World J Gastroenterol 2000; 6: 131-133